ERBB2 and breast carcinoma: Interestingly, this work demonstrated that the majority of examined breast cancer samples (n = 129) showed some degree of staining with SA-β-gal, with luminal A and HER2+ subtypes exhibiting the highest rates of high-SA-β-gal staining [37].